HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark R Bray Selected Research

Interleukins

5/2004Soluble interleukin-13Ralpha2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark R Bray Research Topics

Disease

16Neoplasms (Cancer)
12/2023 - 12/2002
4Breast Neoplasms (Breast Cancer)
01/2022 - 01/2003
4Ovarian Neoplasms (Ovarian Cancer)
01/2013 - 01/2003
2Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
12/2023 - 10/2016
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2023 - 10/2016
2Aneuploidy (Aneuploid)
01/2023 - 01/2017
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
12/2012 - 09/2003
2Multiple Myeloma
01/2011 - 08/2010
1Hematologic Neoplasms (Hematological Malignancy)
12/2023
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2023
1Liver Neoplasms (Liver Cancer)
01/2023
1Neutropenia
01/2019
1Genomic Instability
11/2015
1Triple Negative Breast Neoplasms
01/2013
1Ovarian Epithelial Carcinoma
01/2013
1Rheumatoid Arthritis
12/2012
1Melanoma (Melanoma, Malignant)
01/2011
1Leukemia
01/2011
1Plasmacytoma
08/2010
1Colorectal Neoplasms (Colorectal Cancer)
06/2010
1Carcinoma (Carcinomatosis)
11/2007
1Hodgkin Disease (Hodgkin's Disease)
05/2004
1Neoplasm Metastasis (Metastasis)
01/2003

Drug/Important Bio-Agent (IBA)

10Phosphotransferases (Kinase)IBA
12/2023 - 01/2003
7ENMD 2076IBA
10/2016 - 06/2010
42- (3- (4- ((2,6- dimethylmorpholino)methyl)styryl)- 1H- indazol- 6- yl)- 5'- methoxyspiro(cyclopropane- 1,3'- indolin)- 2'- oneIBA
12/2023 - 08/2014
4Aurora KinasesIBA
10/2016 - 08/2010
3Aurora Kinase AIBA
01/2022 - 06/2010
3PlatinumIBA
01/2013 - 01/2011
2DNA (Deoxyribonucleic Acid)IBA
01/2023 - 09/2003
2CFI-402257IBA
01/2022 - 01/2017
2Tyrosine (L-Tyrosine)FDA Link
01/2011 - 06/2010
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2019
1Immunoglobulin M (IgM)IBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2013
1Estrogen ReceptorsIBA
01/2013
1Estradiol (Delestrogen)FDA LinkGeneric
12/2012
12-MethoxyestradiolIBA
12/2012
1Antimitotic AgentsIBA
12/2012
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2010
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
06/2010
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
06/2010
1EnzymesIBA
11/2007
1Histone Deacetylases (Histone Deacetylase)IBA
04/2005
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
03/2005
1InterleukinsIBA
05/2004
1AutoantibodiesIBA
09/2003
1IntegrinsIBA
01/2003
1Complementary DNA (cDNA)IBA
01/2003
1TensinsIBA
01/2003
1human AKT2 proteinIBA
01/2003
1CollagenIBA
01/2003
1WortmanninIBA
01/2003
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2003
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2003
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2003
1Proteins (Proteins, Gene)FDA Link
01/2003
1Immunoglobulin G (IgG)IBA
12/2002
1Epidermal Growth Factor (EGF)IBA
12/2002

Therapy/Procedure

2Therapeutics
12/2023 - 11/2015
2Oral Administration
01/2017 - 08/2014